Form D Explorer

Form D — Inflammasome Therapeutics, Inc.

0002060536-25-000002 · filed Mar 17, 2025

Offering

Industry: Other Health Care
Exemptions: 06b
Total offering: $10,000,000
Total sold: $2,450,172
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Inflammasome Therapeutics, Inc.
CIK: 1989925
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 57 CHAPEL ST.
NEWTON, MA 02458
Phone: 6173311071

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Paul Ashton · Executive Officer

Newton, MA Find on LinkedIn ↗
Jayakrishna Ambati · Director

Newton, MA Find on LinkedIn ↗
Balamurali Ambati · Director

Newton, MA Find on LinkedIn ↗
Joon Lee · Director

Newton, MA Find on LinkedIn ↗
Mary Weber · Director

Newton, MA Find on LinkedIn ↗
Napoleone Ferrara · Director

Newton, MA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗